Page last updated: 2024-08-21

thiazoles and micafungin

thiazoles has been researched along with micafungin in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	8 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chiou, CC; Hector, R; Mavrogiorgos, N; Tillem, E; Walsh, TJ	1
Habel, F; Hoban, D; Laverdiere, M; Restieri, C	1
Avila, NA; Bacher, J; Casler, HE; Groll, AH; Kelaher, AM; Lyman, CA; Petraitiene, R; Petraitis, V; Sarafandi, AA; Sein, T; Walsh, TJ	1
Bujdáková, H; Melkusová, S; Mikami, Y; Myoken, Y; Volleková, A	1
Steinbach, WJ	1
Baker, CJ; Pannaraj, PS; Walsh, TJ	1
Cano, J; Gené, J; Gilgado, F; Guarro, J; Serena, C	1
González, MP; Teijeira, M; Terán, C	1

Reviews

2 review(s) available for thiazoles and micafungin

Article	Year
Antifungal agents in children. Pediatric clinics of North America, 2005, Volume: 52, Issue:3 Topics: Age Factors; Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Chemistry, Pharmaceutical; Child; Clinical Trials as Topic; Drug Approval; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Patient Selection; Pediatrics; Peptides, Cyclic; Pyrimidines; Safety; Thiazoles; Triazoles; United States; Voriconazole	2005
Search for new antagonist ligands for adenosine receptors from QSAR point of view. How close are we? Medicinal research reviews, 2008, Volume: 28, Issue:3 Topics: Acetamides; Adenosine; Animals; Computer-Aided Design; Drug Design; Echinocandins; Flavanones; Humans; Ligands; Lipopeptides; Lipoproteins; Micafungin; Models, Molecular; Molecular Structure; Purinergic P1 Receptor Antagonists; Purines; Pyrazoles; Pyrimidines; Quantitative Structure-Activity Relationship; Receptors, Purinergic P1; Thiazoles; Xanthines	2008

Article

Year

Antifungal agents in children.

Pediatric clinics of North America, 2005, Volume: 52, Issue:3

Topics: Age Factors; Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Chemistry, Pharmaceutical; Child; Clinical Trials as Topic; Drug Approval; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Patient Selection; Pediatrics; Peptides, Cyclic; Pyrimidines; Safety; Thiazoles; Triazoles; United States; Voriconazole

2005

Search for new antagonist ligands for adenosine receptors from QSAR point of view. How close are we?

Medicinal research reviews, 2008, Volume: 28, Issue:3

Topics: Acetamides; Adenosine; Animals; Computer-Aided Design; Drug Design; Echinocandins; Flavanones; Humans; Ligands; Lipopeptides; Lipoproteins; Micafungin; Models, Molecular; Molecular Structure; Purinergic P1 Receptor Antagonists; Purines; Pyrazoles; Pyrimidines; Quantitative Structure-Activity Relationship; Receptors, Purinergic P1; Thiazoles; Xanthines

2008

Other Studies

6 other study(ies) available for thiazoles and micafungin

Article	Year
Synergy, pharmacodynamics, and time-sequenced ultrastructural changes of the interaction between nikkomycin Z and the echinocandin FK463 against Aspergillus fumigatus. Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:12 Topics: Aminoglycosides; Anti-Bacterial Agents; Antifungal Agents; Aspergillus fumigatus; Drug Synergism; Echinocandins; Kinetics; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Microscopy, Electron; Peptides, Cyclic; Tetrazolium Salts; Thiazoles	2001
In vitro activity of three new triazoles and one echinocandin against Candida bloodstream isolates from cancer patients. The Journal of antimicrobial chemotherapy, 2002, Volume: 50, Issue:1 Topics: Antifungal Agents; Blood; Candida; Candidiasis; Echinocandins; Humans; In Vitro Techniques; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Neoplasms; Peptides, Cyclic; Pyrimidines; Thiazoles; Triazoles; Voriconazole	2002
Combination therapy in treatment of experimental pulmonary aspergillosis: synergistic interaction between an antifungal triazole and an echinocandin. The Journal of infectious diseases, 2003, Jun-15, Volume: 187, Issue:12 Topics: Animals; Aspergillosis; Aspergillus fumigatus; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Echinocandins; Female; Lipopeptides; Lipoproteins; Lung; Lung Diseases, Fungal; Micafungin; Organ Size; Peptides, Cyclic; Rabbits; Thiazoles; Triazoles	2003
The efficiency of the benzothiazole APB, the echinocandin micafungin, and amphotericin B in fluconazole-resistant Candida albicans and Candida dubliniensis. Die Pharmazie, 2004, Volume: 59, Issue:7 Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candidiasis; Drug Resistance, Fungal; Echinocandins; Fluconazole; Humans; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Peptides, Cyclic; Thiazoles	2004
Advances in antifungal therapy. The Pediatric infectious disease journal, 2005, Volume: 24, Issue:10 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anidulafungin; Animals; Antifungal Agents; Caspofungin; Child; Child, Preschool; Clinical Trials as Topic; Echinocandins; Fungal Proteins; Humans; Infant; Infant, Newborn; Lipopeptides; Lipoproteins; Micafungin; Middle Aged; Mycoses; Peptides, Cyclic; Pyrimidines; Thiazoles; Treatment Outcome; Triazoles; Voriconazole	2005
Antifungal susceptibilities of the species of the Pseudallescheria boydii complex. Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:12 Topics: Amphotericin B; Antifungal Agents; Candida; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Naphthalenes; Peptides, Cyclic; Pseudallescheria; Pyrimidines; Quality Control; Quinazolines; Scedosporium; Terbinafine; Thiazoles; Triazoles; Voriconazole	2006